Results 271 to 280 of about 130,683 (338)

Telescopes team up to probe distant worlds. [PDF]

Proc Natl Acad Sci U S A
Mann A.
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Quiet Please: Detrending Radial Velocity Variations from Stellar Activity with a Physically Motivated Spot Model

Jared Siegel, Samuel Halverson, Jacob K. Luhn, Lily Zhao, Khaled Al Moulla, Paul Robertson, Chad F. Bender, Ryan C. Terrien, Arpita Roy, Suvrath Mahadevan, Fred Hearty, Joe P. Ninan, Jason T. Wright, Eric B. Ford, Christian Schwab, Guđmundur Stefánsson, Cullen H. Blake, Michael W. McElwain   +17 more
openalex   +1 more source

A transiting giant planet in orbit around a 0.2-solar-mass host star. [PDF]

Nat Astron
Bryant EM, Jordán A, Hartman JD, Bayliss D, Sedaghati E, Barkaoui K, Chouqar J, Pozuelos FJ, Thorngren DP, Timmermans M, Almenara JM, Chilingarian IV, Collins KA, Gan T, Howell SB, Narita N, Palle E, Rackham BV, Triaud AHMJ, Bakos GÁ, Brahm R, Hobson MJ, Van Eylen V, Amado PJ, Arnold L, Bonfils X, Burdanov A, Cadieux C, Caldwell DA, Casanova V, Charbonneau D, Clark CA, Collins KI, Daylan T, Dransfield G, Demory BO, Ducrot E, Fernández-Rodríguez G, Fukuda I, Fukui A, Gillon M, Gore R, Hooton MJ, Ikuta K, Jehin E, Jenkins JM, Levine AM, Littlefield C, Murgas F, Nguyen K, Parviainen H, Queloz D, Seager S, Sebastian D, Srdoc G, Vanderspek R, Winn JN, de Wit J, Zúñiga-Fernández S.   +58 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Sotatercept: A Crosstalk Between Pathways and Activities in the Pulmonary Circulation and Blood. [PDF]

Int J Mol Sci
Madonna R, Ghelardoni S.
europepmc   +1 more source

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma

Molecular Oncology, EarlyView.
PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga, María Luz Martinez‐Chantar, Carolina Conter   +2 more
wiley   +1 more source

Development and Clinical Evaluation of a Multiplexed Health Surveillance Panel Using Ultra High-Throughput PRM-MS in an Inflammatory Bowel Disease Cohort. [PDF]

Angew Chem Int Ed Engl
Fu Q, Remes PM, Lee J, Jacob C, Li D, Vegesna M, Raedschelders K, Haghani A, Mengesha E, Debbas P, Hoedt E, Joung S, Cheng S, Peterman S, Fert-Bober J, Melmed GY, McGovern DPB, Murray CI, Van Eyk JE.   +18 more
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source